Latanoprost

CAS 130209-82-4 19 API suppliersSmall Molecule

Overview

Latanoprost is a prostaglandin F2α analog used as an ophthalmic solution to lower intraocular pressure in glaucoma patients. It works by increasing the outflow of aqueous fluid from the eyes.

API suppliers (19)

Suppliers of Latanoprost evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

Where these suppliers are
India3Taiwan2Italy2Netherlands1United States1Japan1Belgium1China1

Country recorded for 15 of 19 suppliers.

9 of 19 hold a GMP certificate on record in the EU or UK registers

Patent & exclusivity (US)

Per the FDA Orange Book (9 approved US products), the latest listed US patent on Latanoprost expires 8 Jul 2031. Generic API sourcing typically opens up once these lapse.

Therapeutic areas

OphthalmologyGlaucoma
Verified Supplier Partner

Do you supply Latanoprost? Get in front of buyers actively sourcing it.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.